- Home
- BUSE vs ARDX Comparison
BUSE vs ARDX Comparison
Compare BUSE & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- ARDX
- Stock Information
- Founded
- BUSE 1868
- ARDX 2007
- Country
- BUSE United States
- ARDX United States
- Employees
- BUSE N/A
- ARDX N/A
- Industry
- BUSE Major Banks
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- BUSE Finance
- ARDX Health Care
- Exchange
- BUSE Nasdaq
- ARDX Nasdaq
- Market Cap
- BUSE 1.4B
- ARDX 1.3B
- IPO Year
- BUSE N/A
- ARDX 2014
- Fundamental
- Price
- BUSE $20.82
- ARDX $4.98
- Analyst Decision
- BUSE Buy
- ARDX Strong Buy
- Analyst Count
- BUSE 5
- ARDX 8
- Target Price
- BUSE $27.80
- ARDX $10.19
- AVG Volume (30 Days)
- BUSE 720.4K
- ARDX 5.4M
- Earning Date
- BUSE 04-22-2025
- ARDX 05-01-2025
- Dividend Yield
- BUSE 4.72%
- ARDX N/A
- EPS Growth
- BUSE N/A
- ARDX N/A
- EPS
- BUSE 1.98
- ARDX N/A
- Revenue
- BUSE $453,703,000.00
- ARDX $333,615,000.00
- Revenue This Year
- BUSE $65.20
- ARDX $15.76
- Revenue Next Year
- BUSE $12.01
- ARDX $34.54
- P/E Ratio
- BUSE $10.71
- ARDX N/A
- Revenue Growth
- BUSE 3.25
- ARDX 168.06
- 52 Week Low
- BUSE $18.40
- ARDX $4.02
- 52 Week High
- BUSE $28.97
- ARDX $9.33
- Technical
- Relative Strength Index (RSI)
- BUSE 49.67
- ARDX 51.65
- Support Level
- BUSE $19.55
- ARDX $4.54
- Resistance Level
- BUSE $21.76
- ARDX $5.07
- Average True Range (ATR)
- BUSE 0.90
- ARDX 0.30
- MACD
- BUSE 0.22
- ARDX 0.06
- Stochastic Oscillator
- BUSE 71.73
- ARDX 82.74
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.